drugset / Trial / NCT03751488
A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients
RandomizedParallel-groupOpen-labelTreatment
Summary
This study will look at the Characteristics of LY03010 Versus INVEGA SUSTENNA® in the blood of Schizophrenia Patients
Timeline
- Start
- 2018-12-12
- Primary completion
- 2019-07-24
- Completion
- 2019-07-24
Outcome
Met primary endpoint
release “试 验 结 果 显 示：LY03010与INVEGA SUSTENNA®在 多 次 给 药 达 到 稳 态 时 具 有 生 物 等 效 性.” luye.com ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY03010 | Unknown | 117 mg | — |
| Subject | LY03010 | Unknown | 156 mg | — |
| Subject | LY03010 | Unknown | 351 mg | — |
| Comparator | paliperidone palmitate | Unknown | 156 mg | — |